Cargando…
STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a major global health problem and its treatment options have been limited. Signal transducer and activator of transcription 3 (STAT3) is a transcription factor important for various cellular processes. Overexpression and constitutive activation of STAT3 have been fr...
Autores principales: | Lee, Carol, Cheung, Siu Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895841/ https://www.ncbi.nlm.nih.gov/pubmed/31731457 http://dx.doi.org/10.3390/cancers11111646 |
Ejemplares similares
-
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022) -
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021) -
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
por: Park, Hyunjung, et al.
Publicado: (2023) -
Targeting STAT3 in Cancer with Nucleotide Therapeutics
por: K. Lau, Yue-Ting, et al.
Publicado: (2019) -
JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)